World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Lu JL, Cheng Y, Xu ZL, Qian GX, Wei MT, Jia WD. Immune checkpoint inhibitors plus anti-angiogenesis in patients with resected high-risk hepatitis B virus-associated hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(4): 101371 [PMID: 40235869 DOI: 10.4251/wjgo.v17.i4.101371]
URL:	https://www.wjgnet.com/1948-5204/full/v17/i4/101371.htm

Number	Citing Articles
1	Diptasree Mukherjee, Arunkumar Krishnan. Postoperative immune checkpoint inhibitors plus anti-angiogenesis for hepatitis B virus-associated hepatocellular carcinoma: Analyzing the evidence and future prospects. World Journal of Gastrointestinal Oncology 2025; 17(9): 106801 doi: 10.4251/wjgo.v17.i9.106801 Abstract(74) \| Core Tip(80) \| Full Article(HTML)(174) \| Full Article with Cover (PDF)-722K(53) \| Audio-268K(23) \| Peer-Review Report-225K(38) \| Answering Reviewers-66K(41) \| Full Article (PDF)-396K(61) \| Full Article (XML)-64K(51) \| Times Cited (1) \| Total Visits (1470) \| Open
2	Ziyue Huang, Taifeng Zhu, Xiaokun Chen, Mingjian Piao, Yang Tan, Chengjie Li, Kai Liu, Shanshan Wang, Lei Zhang, Shunda Du, Chengpei Zhu, Kang Zhou, Xiaobo Yang, Daobing Zeng, Haitao Zhao. Postoperative adjuvant TACE combined with lenvatinib and immune checkpoint inhibitors for hepatocellular carcinoma with high recurrence risks: a multicenter retrospective study. BMC Cancer 2026; 26(1) doi: 10.1186/s12885-026-15586-2
3	Erman Akkus, Hatime Arzu Yaşar. Immune Checkpoint Inhibitor–Based Adjuvant Treatment Versus Surveillance in Curatively Treated Hepatocellular Carcinoma: a Systematic Review and Meta‐Analysis. Journal of Gastroenterology and Hepatology 2026; 41(4): 1116 doi: 10.1111/jgh.70318